A. Basu

发表

Cellular Responses to Cisplatin-Induced DNA Damage

Soumya Krishnamurthy, A. Basu, 2010, Journal of nucleic acids.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Regulation of IKKε Expression by Akt2 Isoform.

Soumya Krishnamurthy, A. Basu, 2011, Genes & cancer.

The Enigmatic Protein Kinase C-eta

A. Basu, 2019, Cancers.

The potential of protein kinase C as a target for anticancer treatment.

A. Basu, A Basu, 1993, Pharmacology & therapeutics.

Regulation of Autophagy by Protein Kinase C-ε in Breast Cancer Cells

A. Basu, 2020, International journal of molecular sciences.

Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival.

A. Basu, Deepanwita Pal, S. Outram, 2013, Biochimica et biophysica acta.

Potentiation of tumor necrosis factor-alpha-induced cell death by rottlerin through a cytochrome-C-independent pathway.

A. Basu, Daniel E. Johnson, M. Woolard, 2002, Experimental cell research.

The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.

A. Basu, 1998, Molecular pharmacology.

Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.

N. Saijo, A. Basu, K. Weixel, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Comparison of protein kinase C activity and isoform expression in cisplatin‐sensitive and ‐resistant ovarian carcinoma cells

A. Basu, K. Weixel, 1995, International journal of cancer.

Oncogenic transformation alters cisplatin‐induced apoptosis in rat embryo fibroblasts

A. Basu, Jeffrey S. Cline, 1995, International journal of cancer.

Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II).

B. Teicher, J. Lazo, A. Basu, 1990, The Journal of biological chemistry.

https://researchopenworld.com/ribosomal-s6-kinase-2-promotes-survival-of-triple-negative-breast-cancer-cells-to-apoptotic-stimuli/#

Z. Xuan, A. Basu, Savitha Sridharan, 2019, Cancer Studies and Therapeutics.

Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-α-induced cell death in MCF-7 cells

A. Basu, U. Sivaprasad, 2008, Journal of cellular and molecular medicine.

Protein kinase C-ε protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation

Jie Huang, A. Basu, U. Sivaprasad, 2007, Apoptosis.

Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.

A. Okolo, R. Glew, A. Basu, 1988, Archives of biochemistry and biophysics.

Partial purification and characterization of Naegleria fowleri beta-glucosidase.

A. Saha, T. Nerad, S. Das, 1987, The Journal of protozoology.

The role of metallothioneins in anticancer drug resistance.

R. Bahnson, J. Lazo, A. Basu, 1991, Cancer treatment and research.

A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs.

J. Lazo, A. Basu, 1990, Toxicology letters.

Serum lysosomal hydrolases in cystic fibrosis.

R. Glew, A. Basu, L. Humphries, 1988, Clinica chimica acta; international journal of clinical chemistry.

Comparison of the Acidic Lipid Requirement of Control and Type 1 Gaucher’s Disease Liver and Brain Glucocerebrosidases

B. Butcher, R. Glew, A. Basu, 1988 .

Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.

J. Wherrett, H. Panitch, R. Glew, 1986, Clinica chimica acta; international journal of clinical chemistry.

Comparison of the ability of phospholipids from rat liver lysosomes to reconstitute glucocerebrosidase.

J. Wherrett, R. Glew, A. Basu, 1986, Archives of biochemistry and biophysics.

Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.

R. Glew, A. Basu, E. Prence, 1985, Archives of biochemistry and biophysics.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

Suppression of dexamethasone-induced metallothionein expression and cis-diamminedichloroplatinum(II) resistance by v-mos.

J. Lazo, A. Basu, Alakananda Basu, 1991, Cancer research.

Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin.

J. Lazo, A. Eastman, S. Howell, 1991, Cancer research.

Proteolytic cleavage of p70 ribosomal S6 kinase by caspase-3 during DNA damage-induced apoptosis.

A. Basu, J. R. Mireles, Rohini Dhar, 2009, Biochemistry.

Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway.

A. Basu, C. Basu, B. Adkins, 2008, Cancer research.

Independent Pathway − δ Kinase C-Down-regulation of Caspase-2 by Rottlerin via Protein

A. Basu, C. Basu, B. Adkins, 2008 .

Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.

L. S. Clark, R. Glew, A. Basu, 1984, The Journal of biological chemistry.

Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin

A. Basu, Rohini Dhar, 2008, International journal of oncology.

Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells.

Jie Huang, A. Basu, Shalini D Persaud, 2004, Molecular cancer therapeutics.

Mammalian glucocerebrosidase: implications for Gaucher's disease.

R. Glew, A. Basu, E. Prence, 1988, Laboratory investigation; a journal of technical methods and pathology.

The Effects of Acidic Lipids and Heat-Stable Factor on the Physical-Chemical and Kinetic Properties of Glucocerebrosidase

R. Glew, A. Basu, E. Prence, 1986 .

Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C.

A. Basu, G. Akkaraju, 1999, Biochemistry.

PKCε induces Bcl-2 by activating CREB

Soumya Krishnamurthy, A. Basu, E. Shankar, 2010 .

Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression

W. Siede, A. Basu, Dilip Jain, 2010, Cancer Chemotherapy and Pharmacology.

Isolation and characterization of a fatty acyl esterase from rat lung.

R. Evans, R. Glew, A. Basu, 1988, Archives of biochemistry and biophysics.

Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.

L. S. Clark, R. Glew, A. Basu, 1985, Archives of biochemistry and biophysics.

Overexpression of protein kinase C-eta attenuates caspase activation and tumor necrosis factor-alpha-induced cell death.

A. Basu, G. Akkaraju, 2000, Biochemical and biophysical research communications.

Involvement of proteolytic activation of PKCdelta in cisplatin-induced apoptosis in human small cell lung cancer H69 cells.

Jie Huang, A. Basu, Shalini D Persaud, 2005, International journal of oncology.

Lysosomal storage diseases.

A. Remaley, R. Glew, A. Basu, 1985, Laboratory investigation; a journal of technical methods and pathology.

Synthesis, molecular modeling, 2-D NMR, and biological evaluation of ILV mimics as potential modulators of protein kinase C

Yuan-Ping Pang, Slobodan I Macura, John S. Lazo, 1993 .

Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C.

A. Basu, Ayako Miura, 2002, International journal of molecular medicine.

Protein kinase Cε makes the life and death decision

A. Basu, U. Sivaprasad, Alakananda Basu, 2007 .

Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer

A. Basu, Savitha Sridharan, 2020, International journal of molecular sciences.

Synthesis and biological studies of simplified analogues of lyngbyatoxin A: Use of an isoxazoline-based indole synthesis. Quest for protein kinase C modulators

J. Lazo, A. Kozikowski, A. Basu, 1989 .

Akt Isoforms: A Family Affair in Breast Cancer

A. Basu, C. Lambring, 2021, Cancers.

The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy.

A. Basu, 2021, Pharmacology & therapeutics.

Protein Kinase C-ε Promotes EMT in Breast Cancer

A. Basu, K. Jain, 2014, Breast cancer : basic and clinical research.

Downregulation of Bid is associated with PKCɛ-mediated TRAIL resistance

A. Basu, U. Sivaprasad, E. Shankar, 2007, Cell Death and Differentiation.

Protein Kinase Cϵ Activates Protein Kinase B/Akt via DNA-PK to Protect against Tumor Necrosis Factor-α-induced Cell Death*

Jie Huang, A. Basu, Dongmei Lu, 2006, Journal of Biological Chemistry.

Proteolytic Activation of Protein Kinase C-ε by Caspase-mediated Processing and Transduction of Antiapoptotic Signals*

Jie Huang, A. Basu, A. Moor, 2002, The Journal of Biological Chemistry.

Two Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death

A. Basu, Deepanwita Pal, 2010, TheScientificWorldJournal.

NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner

W. Siede, A. Basu, E. Shankar, 2010, Journal of molecular signaling.

PKC and Resistance to Chemotherapeutic Agents

A. Basu, 2010 .

articleNSC 109268 potentiates cisplatin-induced cell death in a p 53-independent manner

W. Siede, A. Basu, E. Shankar, 2010 .

Overexpression of metallothionein confers resistance to anticancer drugs.

D. Hamer, B. Teicher, J. Lazo, 1988, Science.

Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death.

Jie Huang, A. Basu, Dongmei Lu, 2006, The Journal of biological chemistry.

Manipulation of PKC isozymes by RNA interference and inducible expression of PKC constructs.

A. Basu, U. Sivaprasad, Shalini D Persaud, 2008, Methods in enzymology.

Regulation of Autophagy by Kinases

A. Basu, Savitha Sridharan, K. Jain, 2011, Cancers.

Protein kinase Cɛ confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53

A. Basu, U. Sivaprasad, E. Shankar, 2008, Oncogene.

The Multifunctional Protein Kinase C-ε in Cancer Development and Progression

A. Basu, K. Jain, 2014, Cancers.

Novel regulation of protein kinase C-η.

A. Basu, Deepanwita Pal, S. Outram, 2012, Biochemical and biophysical research communications.

S6 kinase 2 promotes breast cancer cell survival via Akt.

A. Basu, Savitha Sridharan, 2011, Cancer research.

Molecular and Cellular Pathobiology S 6 Kinase 2 Promotes Breast Cancer Cell Survival via Akt

A. Basu, Savitha Sridharan, 2011 .

Emerging therapeutics for targeting Akt in cancer.

A. Basu, Andrew S. Gdowski, Timothy Van Treuren, 2016, Frontiers in bioscience.

Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2

A. Basu, Savitha Sridharan, 2017, PloS one.

Autophagy in breast cancer and its implications for therapy.

A. Basu, Savitha Sridharan, K. Paranandi, 2013, American journal of cancer research.

Synthesis of structural analogues of lyngbyatoxin A and their evaluation as activators of protein kinase C.

J. Lazo, A. Kozikowski, A. Basu, 1991, Journal of medicinal chemistry.

The Emerging Roles of mTORC1 in Macromanaging Autophagy

Akpedje S Dossou, A. Basu, 2019, Cancers.

Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta.

A. Basu, Haidi Tu, 2005, Biochemical and biophysical research communications.

P300 regulates the human RLIP76 promoter activity and gene expression.

Y. Awasthi, S. Awasthi, A. Basu, 2013, Biochemical pharmacology.

Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.

J. Lazo, A. Basu, 1992, Cancer research.

Differential sensitivity of breast cancer cells to tumor necrosis factor-alpha: involvement of protein kinase C.

A. Basu, S. Mohanty, B. Sun, 2001, Biochemical and biophysical research communications.

Involvement of protein kinase C-δ in DNA damage-induced apoptosis

C. L. Johnson, A. Basu, M. Woolard, 2001, Cell Death and Differentiation.

Regulation of p53 stabilization by DNA damage and protein kinase C.

Jie Huang, A. Basu, Dongmei Lu, 2002, Molecular cancer therapeutics.

Protein kinase C-eta regulates Mcl-1 level via ERK1.

A. Basu, Deepanwita Pal, 2017, Cellular signalling.

The unique protein kinase Cη: implications for breast cancer (review).

A. Basu, Deepanwita Pal, 2014, International journal of oncology.

Overexpression of protein kinase C-η attenuates caspase activation and tumor necrosis factor-α-induced cell death

A. Basu, G. Akkaraju, 2000 .

Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.

A. Basu, U. Sivaprasad, E. Shankar, 2007, Cell death and differentiation.

Comparison of effects of growth factors and protein kinase C activators on cellular sensitivity to cis‐diamminedichloroplatinum(II)

R. Evans, A. Basu, 1994, International journal of cancer.

Structural requirements of lyngbyatoxin A for activation and downregulation of protein kinase C.

J. Lazo, A. Kozikowski, A. Basu, 1992, Biochemistry.

Molecular Targets of Breast Cancer: AKTing in Concert

A. Basu, 2008, Breast cancer : basic and clinical research.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

PKCε paves the way for prostate cancer

A. Basu, 2011, Cell Cycle.

Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652

Lee, Duchen, Izzo, 2016 .

Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.

J. Lazo, A. Kozikowski, A. Basu, 1991, Cancer research.

Involvement of protein kinase C-delta in DNA damage-induced apoptosis.

C. L. Johnson, A. Basu, A Basu, 2001, Cell death and differentiation.

Protein kinase Cepsilon makes the life and death decision.

A. Basu, U. Sivaprasad, Alakananda Basu, 2007, Cellular signalling.

Enhancement of Cisplatin Sensitivity of Cisplatin-Resistant Human Cervical Carcinoma Cells by Bryostatin 1

Jie Huang, A. Basu, S. Mohanty, 2005, Clinical Cancer Research.

COMPARISON OF PROTEIN KINASE C ACTIVITY AND ISOFORM OVARIAN CARCINOMA CELLS EXPRESSION IN CISPLATIN-SENSITIVE AND -RESISTANT

A. Basu, K. Weixel, 2006 .

Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2.

A. Basu, Savitha Sridharan, Shalini D Persaud, 2009, Cellular signalling.

Cisplatin resistance is associated with deregulation in protein kinase C-delta.

Jie Huang, A. Basu, S. Mohanty, 2004, Biochemical and biophysical research communications.

PKCepsilon induces Bcl-2 by activating CREB.

Soumya Krishnamurthy, A. Basu, E. Shankar, 2010, International journal of oncology.

Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation.

Jie Huang, A. Basu, U. Sivaprasad, 2007, Apoptosis : an international journal on programmed cell death.

Differential effects of protein kinase C-eta on apoptosis versus senescence.

A. Basu, Deepanwita Pal, R. Blaydes, 2019, Cellular signalling.

Effect of acid-base changes on urinary hydrolases in Fabry's disease after renal transplantation.

R. Glew, A. Basu, S. Adler, 1990, The Journal of laboratory and clinical medicine.